Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy

被引:0
作者
Mittra, Erik [1 ]
Bodei, Lisa [2 ]
机构
[1] Oregon Hlth & Sci Univ, Div Nucl Med & Mol Imaging, Portland, OR 97201 USA
[2] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1031 / 1032
页数:2
相关论文
共 3 条
[1]   PSMA ligands in prostate cancer - Probe optimization and theranostic applications [J].
Luetje, Susanne ;
Slavik, Roger ;
Fendler, Wolfgang ;
Herrmann, Ken ;
Eiber, Matthias .
METHODS, 2017, 130 :42-50
[2]   Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models [J].
Marsh, Ian R. ;
Grudzinski, Joseph ;
Baiu, Dana C. ;
Besemer, Abigail ;
Hernandez, Reinier ;
Jeffery, Justin J. ;
Weichert, Jamey P. ;
Otto, Mario ;
Bednarz, Bryan P. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (10) :1414-1420
[3]  
MatthiasDHuyvetter M, 2020, J NUCL MED